{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06417229",
            "orgStudyIdInfo": {
                "id": "CA228-1011"
            },
            "organization": {
                "fullName": "Celgene",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants",
            "officialTitle": "A Phase 1, Two-part, Open-label Single Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BMS-986365, Food and Proton Pump Inhibitor Effects, and Relative Bioavailability of BMS-986365 Capsule Compared to Tablet Formulation in Healthy Adult Male Participants",
            "therapeuticArea": [
                "Other"
            ],
            "study": "study-to-evaluate-safety-drug-levels-food-and-relative-bioavailability-of-bms-in-healthy-adult-male-participants"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11-18",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-10",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-05-13",
            "studyFirstSubmitQcDate": "2024-05-13",
            "studyFirstPostDateStruct": {
                "date": "2024-05-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-27",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Celgene",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate the safety, tolerability, drug levels, food effects and relative bioavailability of BMS-986365 in healthy male participants."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy Participants"
            ],
            "keywords": [
                "BMS-986365",
                "Pharmacokinetics",
                "Relative Bioavailability",
                "Healthy Male Volunteers",
                "CC-94676",
                "Food Effect",
                "Proton Pump Inhibitor"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 82,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part 1: Cohort 1 BMS-986365 Dose 1",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: BMS-986365"
                    ]
                },
                {
                    "label": "Part 1: Cohort 2 BMS-986365 Dose 2 Formulation 1",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: BMS-986365"
                    ]
                },
                {
                    "label": "Part 1: Cohort 2 BMS-986365 Dose 3 Formulation 2",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: BMS-986365"
                    ]
                },
                {
                    "label": "Part 1: Cohort 3 BMS-986365 Dose 4",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: BMS-986365"
                    ]
                },
                {
                    "label": "Part 1: Cohort 6 BMS-986365 Dose 5",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: BMS-986365"
                    ]
                },
                {
                    "label": "Part 1: Cohort 7 BMS-986365 Dose 6",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: BMS-986365"
                    ]
                },
                {
                    "label": "Part 1: Cohort 8 BMS-986365 Dose 7",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: BMS-986365"
                    ]
                },
                {
                    "label": "Part 2: Cohort 4 BMS-986365 Dose 8 Fasted",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: BMS-986365"
                    ]
                },
                {
                    "label": "Part 2: Cohort 4 BMS-986365 Dose 9 Fed",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: BMS-986365"
                    ]
                },
                {
                    "label": "Part 2: Cohort 5 BMS-986365 Dose 10 Fasted Followed by Rabeprazole + Rabeprazole and BMS-986365",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Rabeprazole"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "BMS-986365",
                    "description": "Specified dose on specified days",
                    "armGroupLabels": [
                        "Part 1: Cohort 1 BMS-986365 Dose 1",
                        "Part 1: Cohort 2 BMS-986365 Dose 2 Formulation 1",
                        "Part 1: Cohort 2 BMS-986365 Dose 3 Formulation 2",
                        "Part 1: Cohort 3 BMS-986365 Dose 4",
                        "Part 1: Cohort 6 BMS-986365 Dose 5",
                        "Part 1: Cohort 7 BMS-986365 Dose 6",
                        "Part 1: Cohort 8 BMS-986365 Dose 7",
                        "Part 2: Cohort 4 BMS-986365 Dose 8 Fasted",
                        "Part 2: Cohort 4 BMS-986365 Dose 9 Fed"
                    ],
                    "otherNames": [
                        "CC-94676"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Rabeprazole",
                    "description": "Specified dose on specified days",
                    "armGroupLabels": [
                        "Part 2: Cohort 5 BMS-986365 Dose 10 Fasted Followed by Rabeprazole + Rabeprazole and BMS-986365"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Maximum observed plasma concentration (Cmax)",
                    "timeFrame": "Up to Day 75"
                },
                {
                    "measure": "Area under the plasma concentration-time curve from time zero to time of the last quantifiable concentration [AUC(0-T)]",
                    "timeFrame": "Up to Day 75"
                },
                {
                    "measure": "Area under the plasma concentration-time curve from time zero extrapolated to infinite time [AUC(INF)]",
                    "timeFrame": "Up to Day 75"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "To assess the bioavailability of BMS-986365 experimental formulation relative to the reference formulation",
                    "timeFrame": "Up to Day 75"
                },
                {
                    "measure": "Incidence of adverse events (AE)",
                    "timeFrame": "Up to Day 75"
                },
                {
                    "measure": "Incidence of serious adverse events (SAE)",
                    "timeFrame": "Up to Day 75"
                },
                {
                    "measure": "Number of participants with physical examination abnormalities",
                    "timeFrame": "Up to Day 75"
                },
                {
                    "measure": "Number of participants with vital sign abnormalities",
                    "timeFrame": "Up to Day 75"
                },
                {
                    "measure": "Number of participants with clinical laboratory abnormalities",
                    "timeFrame": "Up to Day 75"
                },
                {
                    "measure": "Number of participants with electrocardiogram (ECG) abnormalities",
                    "timeFrame": "Up to Day 75"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Healthy adult male participants as determined by no clinically significant deviations from normal in medical history, physical examination, vital signs, ECGs, echocardiogram, or clinical laboratory assessments as determined by the investigator.\n* Body mass index (BMI) of 18.0 to 32.0 kg/m\\^2, inclusive.\n\nExclusion Criteria:\n\n* Any significant acute or chronic illness.\n* Prior history of heart failure, ischemic heart diseases, serious cardiac arrythmias, or prolonged QT interval.\n* History of allergy/hypersensitivity to any component (including excipients) of BMS-986365 study interventions or related compounds.\n* Other protocol-defined inclusion/exclusion criteria apply.",
            "healthyVolunteers": true,
            "sex": "MALE",
            "minimumAge": "18 Years",
            "maximumAge": "60 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "BMS Study Connect Contact Center www.BMSStudyConnect.com",
                    "role": "CONTACT",
                    "phone": "855-907-3286",
                    "email": "Clinical.Trials@bms.com"
                },
                {
                    "name": "First line of the email MUST contain NCT # and Site #.",
                    "role": "CONTACT"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Bristol-Myers Squibb",
                    "affiliation": "Bristol-Myers Squibb",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "ICON Lenexa",
                    "status": "RECRUITING",
                    "city": "Lenexa",
                    "state": "Kansas",
                    "zip": "66219",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Patrick Yao, Site 0001",
                            "role": "CONTACT",
                            "phone": "913-410-2674"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.95362,
                        "lon": -94.73357
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "BMS Clinical Trial Information",
                    "url": "https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html"
                },
                {
                    "label": "FDA Safety Alerts and Recalls",
                    "url": "http://www.fda.gov/MEDWATCH/safety.htm"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria.\n\nAdditional information regarding Bristol Myer Squibb's data sharing policy and process can be found at: https://www.bms.com/researchers-and-partners/clinical-trials-and research/disclosurecommitment.html"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000064750",
                    "term": "Rabeprazole"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000897",
                    "term": "Anti-Ulcer Agents"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000054328",
                    "term": "Proton Pump Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M30382",
                    "name": "Rabeprazole",
                    "asFound": "Continuous infusion",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27630",
                    "name": "Proton Pump Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4188",
                    "name": "Antacids",
                    "relevance": "LOW"
                },
                {
                    "id": "M4219",
                    "name": "Anti-Ulcer Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}